COVID-19 Also Hazardous for Middle-Aged Adults
TUESDAY, Jan. 26, 2021 -- COVID-19 is dangerous for middle-aged adults, with an estimated age-specific infection fatality rate (IFR) of 0.4 and 1.4 percent at ages 55 and 65 years, respectively, according to a review published online Dec. 8 in the European Journal of Epidemiology.
Andrew T. Levin, Ph.D., from Dartmouth College in Hanover, New Hampshire, and colleagues conducted a systematic review and meta-analysis of 27 studies covering 34 geographic locations to examine age-specific IFRs for COVID-19.
The researchers identified an exponential relationship between age and IFR for COVID-19. For children and younger adults, the estimated age-specific IFR was very low (for example, 0.002 percent at age 10 years; 0.01 percent at age 25 years), but it increased progressively to 0.4, 1.4, 4.6, and 15 percent at ages 55, 65, 75, and 85 years, respectively. About 90 percent of the variation in population IFR across geographic regions reflected differences in the age composition of the population and the extent of exposure to the virus for vulnerable age groups.
"For a person who is middle-aged, the risk of dying from COVID-19 is about 100 times greater than dying from an automobile accident," Levin said in a statement. "Generally speaking, very few children and young adults die of COVID-19. However, the risk is progressively greater for middle-aged and older adults."
© 2021 HealthDay. All rights reserved.
Posted: January 2021
Further Support and Information on COVID-19
Read this next
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of March 1 to 5, 2021. This roundup...
FRIDAY, March 5, 2021 -- Countries worldwide are struggling to find enough syringes to administer COVID-19 vaccines. Experts say between 8 billion and 10 billion syringes are...
FRIDAY, March 5, 2021 -- Two cases of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant P.1 identified in Minnesota are described in a report published in...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.